Correlation analysis of pharmacokinetic parameters of docetaxel AUC and adverse reactions in breast cancer patients
BackgroundDocetaxel is commonly used in breast cancer chemotherapy. The previous drug dose is generally calculated based on body surface area (BSA). However, the metabolism varies greatly among different patients. Docetaxel therapeutic drug monitoring (TDM) helps monitor adverse drug reactions and e...
Saved in:
| Main Authors: | Yongzhe Tang, Yamin Liu, Shengying Qin, Cong Huai, Jin Zhang, Weijie Ding, Junwei Fan, Jie Wang, Xiaoqing Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1563506/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of vancomycin trough levels, AUC and AUC/MIC ratios with clinical outcomes in patients with enterococcal bacteremia: a prospective cohort study
by: Eda Kubra Sel, et al.
Published: (2025-07-01) -
Docetaxel Micelles: A New Formulation to Diminish Hypersensitivity Reactions
by: Lanlan Xiang, et al.
Published: (2025-02-01) -
Evaluating AUC estimators across complex sampling designs: insights from COVID-19 patient data
by: Amaia Iparragirre, et al.
Published: (2025-08-01) -
Metformin-Sensitized Chemotherapy of Docetaxel Nanoemulsions Based on a Sequential Administration
by: Junlei Zhang, et al.
Published: (2025-06-01) -
Feasibility and Safety of Anlotinib Plus Docetaxel versus Docetaxel Monotherapy in Patients with Previously Immunotherapy-Treated NSCLC: A Retrospective Exploratory Study
by: Li DW, et al.
Published: (2025-04-01)